Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; Avdoralimab (IPH5401), a monoclonal antibody blocking C5a binding to C5aR1 that is in Phase II clinicals trials for the treatment of COVID-19, bullous pemphigoid, chronic spontaneous urticaria, and other inflammatory diseases; IPH5201, a blocking antibody that is in Phase 1 clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; and IPH6101, a NKp46-based NK cell engager for the generation and evaluation of up to two bispecific NK cell engagers. Its products in preclinical trials are IPH43, an anti-MICA/B antibody drug conjugate; Anti-Siglec-9, an antibody program; IPH65, a tetraspecific proprietary antibody; IPH25, a checkpoint inhibitor; and IPH62 and IPH64 programs. Innate Pharma S.A. has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. The company was incorporated in 1999 and is headquartered in Marseille, France. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Innate Pharma S.A. ADS.
Innate Pharma S.A. ADS business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Innate Pharma S.A. ADS are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Innate Pharma S.A. ADS , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Innate Pharma S.A. ADS including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Innate Pharma S.A. ADS and all latest updates of the company are provided.
The 2025 version of Innate Pharma S.A. ADS report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Innate Pharma S.A. ADS- Key Facts
2.2 Innate Pharma S.A. ADS- Geographic Locations
2.3 Innate Pharma S.A. ADS- Subsidiaries and Affiliates
2.4 Innate Pharma S.A. ADS- Business Divisions
2.5 Innate Pharma S.A. ADS- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Innate Pharma S.A. ADS Strategic Analysis Review
3.1 Innate Pharma S.A. ADS- Key Strategies
3.2 Innate Pharma S.A. ADS- Company Outlook Statement
3.3 Innate Pharma S.A. ADS- SWOT Analysis
3.3.1 Innate Pharma S.A. ADS- Key Strengths
3.3.2 Innate Pharma S.A. ADS- Key Weaknesses
3.3.3 Innate Pharma S.A. ADS- Potential Opportunities
3.3.4 Innate Pharma S.A. ADS- Potential Threats
3.4 Innate Pharma S.A. ADS- Key Competitors
4. Business Description of the Company
4.1 Innate Pharma S.A. ADS- Business Overview
4.2 Innate Pharma S.A. ADS- Operations by Segment
5 Products and Services Details
5.1 Innate Pharma S.A. ADS- Key Products
5.2 Innate Pharma S.A. ADS- Key Service Areas
5.3 Innate Pharma S.A. ADS- Key Brands
6 Company Developments
6.1 Innate Pharma S.A. ADS- Company History
6.2 Innate Pharma S.A. ADS- Latest Developments
7 Financial Analysis
7.1 Innate Pharma S.A. ADS- Income Statements
7.2 Innate Pharma S.A. ADS- Balance Sheet
7.3 Innate Pharma S.A. ADS- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Innate Pharma S.A. ADS- Direct Competitors
8.2 Innate Pharma S.A. ADS- Competitor Financial Ratios comparison
8.3 Innate Pharma S.A. ADS- Competitor Stock Charts Comparison
8.4 Innate Pharma S.A. ADS- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!